Immunovant, Inc. SEC filings IMVT
Immunovant, Inc. has 648 filings in SEC EDGAR's recent list, going back to Jan 23, 2019. Its latest annual report, Form ARS, was filed on Jul 22, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 3, 2026 (shareholder vote results). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Dec 12, 2025 | — |
| FWP | Free writing prospectus | Dec 11, 2025 | — |
| S-8 | Employee stock plan registration | Apr 30, 2025 | — |
| 424B3 | Prospectus | Jan 24, 2025 | — |
| S-8 | Employee stock plan registration | Apr 15, 2024 | — |
| S-3ASR | Automatic shelf registration | Nov 9, 2023 | — |
| 424B5 | Prospectus supplement | Sep 29, 2023 | — |
| FWP | Free writing prospectus | Sep 28, 2023 | — |
| FWP | Free writing prospectus | Sep 27, 2023 | — |
| 424B5 | Prospectus supplement | Sep 26, 2023 | — |
| S-8 | Employee stock plan registration | Apr 5, 2023 | — |
| S-8 | Employee stock plan registration | Feb 3, 2023 | — |
| 424B5 | Prospectus supplement | Oct 5, 2022 | — |
| S-8 | Employee stock plan registration | Jun 8, 2022 | — |
| S-8 | Employee stock plan registration | Jan 10, 2022 | — |
| 424B7 | Filing | Jan 15, 2021 | — |
| 424B5 | Prospectus supplement | Jan 15, 2021 | — |
| S-3 | Shelf registration | Jan 4, 2021 | — |
| 424B3 | Prospectus | Nov 12, 2020 | — |
| 424B4 | Prospectus | Sep 3, 2020 | — |
| S-1MEF | Filing | Sep 1, 2020 | — |
| S-1 | Registration statement | Aug 31, 2020 | — |
| 424B3 | Prospectus | Aug 25, 2020 | — |
| 424B3 | Prospectus | Aug 21, 2020 | — |
| 424B3 | Prospectus | Aug 12, 2020 | — |
| S-8 | Employee stock plan registration | Jun 29, 2020 | — |
| 424B3 | Prospectus | Jun 29, 2020 | — |
| 424B4 | Prospectus | Apr 14, 2020 | — |
| S-1MEF | Filing | Apr 14, 2020 | — |
| S-1 | Registration statement | Apr 10, 2020 | — |
| 424B3 | Prospectus | Apr 10, 2020 | — |
| S-1/A | Amended registration statement | Apr 8, 2020 | — |
| S-1/A | Amended registration statement | Apr 3, 2020 | — |
| S-1/A | Amended registration statement | Feb 28, 2020 | — |
| S-8 | Employee stock plan registration | Feb 26, 2020 | — |
| S-1 | Registration statement | Jan 17, 2020 | — |
| 424B4 | Prospectus | May 10, 2019 | — |
| S-1/A | Amended registration statement | May 3, 2019 | — |
| S-1/A | Amended registration statement | Apr 29, 2019 | — |
| S-1 | Registration statement | Apr 16, 2019 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IMVT (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1764013
- Former names
- Health Sciences Acquisitions Corp (until Dec 20, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.